The Global Digital Pathology Market is expected to witness around 14% CAGR during 2022-27, says MarkNtel Advisors in their research report. The increasing focus of the healthcare industry towards digitalization for the expedition of work, coupled with increasing investments in the healthcare sector by both public & private sectors, are the key aspects driving the Digital Pathology Market globally.
With the rise in its healthcare applications, such as primary diagnosis, intraoperative diagnosis, medical student & resident training, diagnostic consultations, clinical research, and tumor boards, the market has witnessed considerable growth in recent years, further states the research report, “Global Digital Pathology Market Analysis, 2022.”
Biotechnologies & Pharma Companies to Attain the Largest Share of the Global Digital Pathology Market during 2022-27
The burgeoning application of digital pathology solutions in drug discovery studies & drug toxicology testing has propagated their demand in biotechnology & pharma companies. Digital pathology assists in delivering organized and documented archival, retrieval, & logistical procedures to pharma & biopharma companies with easy data retrieval among different pathologists. For instance:
· In 2021, UK-based Nottingham University Hospitals (NUH) NHS Trust announced to deploy Indica Labs' HALO AP digital pathology software for managing & viewing scanned slides for primary diagnosis, secondary consultations, tumor boards, remote reporting, & multi-disciplinary team meetings.
Furthermore, healthcare service providers are also well-contributing to the accelerated demand for digital pathology solutions over the past few years and shall attain a notable market share during 2022-27
With the Increasing Integration of New Systems in Healthcare, Software Grabbed a Notable Market Share in North America
The high concentration of world-class software companies, especially in the US, coupled with the flourishing efforts towards healthcare automation by the regional governments, are the prime aspects driving the Digital Pathology Market in North America. As a result, the demand for digital pathology software across the region is expected to elevate in the forecast years. For instance:
Moreover, increasing investments in integrating digital pathology solutions into the healthcare sector and the mounting focus on research & drug developments are other crucial factors encouraging the overall market growth across North America through 2027, further reveals MarkNtel Advisors in their research report, “Global Digital Pathology Market Analysis, 2022.”
According to MarkNtel Advisors, the leading players in the Global Digital Pathology Market are Nikon Instrument Inc., Omnyx llc, Pathcentral Inc., Pathxl, Pixcelldata Ltd., Sunquest Information System, Ventana Medical Systems Inc., Visiopharm, & Xifin.
Key Questions Answered in the Study